You are here:   Videos
Register   |  Login

Get Adobe Flash player Install latest flash player if this video gallery doesn't work.
Progression-Free Survival from a Phase 1 Study of Crizotinib (PF-02341066) in Patients with ALK-Positive Non-Small Cell Lung Cancer
From ASCO 2011 – A discussion with D. Ross Camidge, MD, PhD, Director of Thoracic Oncology Clinical Program Faculty and Associate Professor of Medicine/Oncology Division of Medical Oncology at the University of Colorado, the Anschutz Medical Campus.
Recent Video
| 
Most Viewed
Tumor Type : Search :